These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24140674)

  • 1. Increased vasopressin 1A receptor expression in failing human hearts.
    Zhu W; Tilley DG; Myers VD; Tsai EJ; Feldman AM
    J Am Coll Cardiol; 2014 Feb; 63(4):375-6. PubMed ID: 24140674
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
    Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
    Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of arginine vasopressin and its receptors in the normal and failing rat heart.
    Chandrashekhar Y; Prahash AJ; Sen S; Gupta S; Roy S; Anand IS
    J Mol Cell Cardiol; 2003 May; 35(5):495-504. PubMed ID: 12738231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vasopressin receptor antagonists in therapy of congestive heart failure].
    Gassanov N; Taghiyev Z; Le MT; Biesenbach E; Baldus S; Er F
    Dtsch Med Wochenschr; 2013 Nov; 138(45):2313-8. PubMed ID: 24163168
    [No Abstract]   [Full Text] [Related]  

  • 5. Arginine vasopressin receptor signaling and functional outcomes in heart failure.
    Wasilewski MA; Myers VD; Recchia FA; Feldman AM; Tilley DG
    Cell Signal; 2016 Mar; 28(3):224-233. PubMed ID: 26232615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulating G protein-coupled receptors: cure or cause for heart failure?
    Vatner DE
    Circ Res; 2001 Apr; 88(7):645-7. PubMed ID: 11304483
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of Molecular Mechanisms Underlying Cardioprotective Action of the ALM-802 Compound.
    Kozhevnikova LM; Barchukov VV; Semenova NP; Vititnova MB; Kryzhanovskii SA
    Bull Exp Biol Med; 2021 Jan; 170(3):312-315. PubMed ID: 33452980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure.
    Owen VJ; Burton PB; Mullen AJ; Birks EJ; Barton P; Yacoub MH
    Eur Heart J; 2001 Jun; 22(12):1015-20. PubMed ID: 11428836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility.
    Laugwitz KL; Weig HJ; Moretti A; Hoffmann E; Ueblacker P; Pragst I; Rosport K; Schömig A; Ungerer M
    Circ Res; 2001 Apr; 88(7):688-95. PubMed ID: 11304491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardin mRNA is augmented in the failing myocardium: expression profiling in the porcine model and human dilated cardiomyopathy.
    Torrado M; López E; Centeno A; Medrano C; Castro-Beiras A; Mikhailov AT
    J Mol Med (Berl); 2003 Sep; 81(9):566-77. PubMed ID: 12920479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the Mechanism of the Cardioprotective Action of σ
    Kryzhanovskii SA; Kozhevnikova LM; Tsorin IB; Sukhanova IF; Ionova EO; Stolyaruk VN; Vititnova MB; Miroshkina IA; Seredenin SB
    Bull Exp Biol Med; 2018 Sep; 165(5):660-664. PubMed ID: 30225699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of mRNA specific for beta 1- and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods.
    Ihl-Vahl R; Eschenhagen T; Kübler W; Marquetant R; Nose M; Schmitz W; Scholz H; Strasser RH
    J Mol Cell Cardiol; 1996 Jan; 28(1):1-10. PubMed ID: 8745209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival?
    Scheubel RJ; Bartling B; Simm A; Silber RE; Drogaris K; Darmer D; Holtz J
    J Am Coll Cardiol; 2002 Feb; 39(3):481-8. PubMed ID: 11823087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats.
    Bucher M; Hobbhahn J; Taeger K; Kurtz A
    Am J Physiol Regul Integr Comp Physiol; 2002 Apr; 282(4):R979-84. PubMed ID: 11893600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium sensitisers: mechanisms of action and potential usefulness as inotropes.
    Lee JA; Allen DG
    Cardiovasc Res; 1997 Oct; 36(1):10-20. PubMed ID: 9415267
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional arginine vasopressin system in early heart maturation.
    Gutkowska J; Miszkurka M; Danalache B; Gassanov N; Wang D; Jankowski M
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2262-70. PubMed ID: 17630342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deloading of the left ventricle by ventricular assist device normalizes increased expression of endothelin ET(A) receptors but not endothelin-converting enzyme-1 in patients with end-stage heart failure.
    Morawietz H; Szibor M; Goettsch W; Bartling B; Barton M; Shaw S; Koerfer R; Zerkowski HR; Holtz J
    Circulation; 2000 Nov; 102(19 Suppl 3):III188-93. PubMed ID: 11082385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? II. Protagonist's viewpoint.
    Packer M
    J Am Coll Cardiol; 1988 Aug; 12(2):562-6. PubMed ID: 3392349
    [No Abstract]   [Full Text] [Related]  

  • 19. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium.
    Arai M; Alpert NR; MacLennan DH; Barton P; Periasamy M
    Circ Res; 1993 Feb; 72(2):463-9. PubMed ID: 8418995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression.
    Tsutsumi Y; Matsubara H; Ohkubo N; Mori Y; Nozawa Y; Murasawa S; Kijima K; Maruyama K; Masaki H; Moriguchi Y; Shibasaki Y; Kamihata H; Inada M; Iwasaka T
    Circ Res; 1998 Nov; 83(10):1035-46. PubMed ID: 9815151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.